Latest Quarter
2025-12-31
Propanc Biopharma Inc (PPCBD)
Revenue
$0.0
Net Income
-$3.1M
Operating Margin
N/A
Free Cash Flow
-$405K
Debt / Assets
29.2%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | 6,032 | 3,702 | 0 | 4,332 |
| Gross Profit | -6,032 | -3,702 | 0 | 0 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 3,628,741 | 4,613,363 | 0 | 158,994 |
| Operating Expenses | 3,654,734 | 4,673,564 | 53,128,713 | 209,050 |
| Operating Income | -3,654,734 | -4,673,564 | -53,128,713 | -213,382 |
| Interest Expense | 58,955 | 305,649 | -104,042 | 118,943 |
| Income Before Tax | -3,091,394 | -4,837,738 | -54,067,346 | -430,183 |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | -3,091,394 | -4,837,738 | -54,067,346 | -430,183 |
| Per Share | ||||
| EPS | -0.30 | -0.39 | -12.50 | -32.23 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2020-06-30 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 21,656 | 17,760 | 0 | 0 |
| Gross Profit | 0 | -21,656 | -17,760 | 0 | 0 |
| Operating Expenses | |||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 57,054,410 | 1,288,000 | 1,511,000 | 1,734,818 | 0 |
| Operating Expenses | 57,278,131 | 1,514,000 | 1,759,000 | 1,990,870 | 3,494,260 |
| Operating Income | -57,278,131 | -1,536,000 | -1,777,000 | -1,990,870 | -3,494,260 |
| Interest Expense | 563,757 | 665,841 | 532,821 | 568,798 | 1,748,381 |
| Income Before Tax | -58,923,300 | -1,950,000 | -2,790,000 | -2,713,064 | -4,740,723 |
| Income Tax Expense | 0 | -129,000 | -130,000 | -54,977 | 0 |
| Net Income | -58,923,300 | -1,821,000 | -2,661,000 | -2,658,087 | -4,740,723 |
| Per Share | |||||
| EPS | -14.85 | -1,420.95 | -31,268.39 | -38.96 | -0.19 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-06-30 | 2024-06-30 | 2022-06-30 | 2020-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Cash and Cash Equivalents | 12,088 | 21,085 | 4,067 | 67,007 |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 5,302 | 2,950 | 2,342 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | 8,352,816 | 25,441 | 15,030 | 69,022 |
| Property Plant Equipment | 59,413 | 17,799 | 64,546 | 5,747 |
| Goodwill and Intangibles | 0 | 0 | 0 | 0 |
| Total Assets | 19,631,808 | 72,365 | 81,651 | 74,769 |
| Liabilities | ||||
| Account Payables | 1,249,596 | 1,213,335 | 943,023 | 842,156 |
| Short Term Debt | 1,579,506 | 889,629 | 1,056,036 | 0 |
| Total Current Liabilities | 5,578,240 | 3,792,782 | 3,062,981 | 3,739,943 |
| Long Term Debt | 147,376 | 58,642 | 42,319 | 0 |
| Total Liabilities | 5,725,616 | 3,851,424 | 3,105,300 | 3,739,943 |
| Shareholders Equity | ||||
| Retained Earnings | -125,621,520 | -66,698,220 | -61,557,893 | 0 |
| Total Shareholders Equity | 13,906,192 | -3,779,059 | -3,023,649 | -3,641,425 |
| Balance Sheet (Annual) | 2025-06-30 | 2024-06-30 | 2022-06-30 | 2020-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Cash and Cash Equivalents | 12,088 | 21,085 | 4,067 | 67,007 |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 5,302 | 2,950 | 2,342 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Total Current Assets | 8,352,816 | 25,441 | 15,030 | 69,022 |
| Property Plant Equipment | 59,413 | 17,799 | 64,546 | 5,747 |
| Goodwill and Intangibles | 0 | 0 | 0 | 0 |
| Total Assets | 19,631,808 | 72,365 | 81,651 | 74,769 |
| Liabilities | ||||
| Account Payables | 1,249,596 | 1,213,335 | 943,023 | 842,156 |
| Short Term Debt | 1,579,506 | 889,629 | 1,056,036 | 0 |
| Total Current Liabilities | 5,578,240 | 3,792,782 | 3,062,981 | 3,739,943 |
| Long Term Debt | 147,376 | 58,642 | 42,319 | 0 |
| Total Liabilities | 5,725,616 | 3,851,424 | 3,105,300 | 3,739,943 |
| Shareholders Equity | ||||
| Retained Earnings | -125,621,520 | -66,698,220 | -61,557,893 | 0 |
| Total Shareholders Equity | 13,906,192 | -3,779,059 | -3,023,649 | -3,641,425 |
| Cash Flow Statement (Quarterly) | 2025-06-30 | 2024-06-30 | 2022-06-30 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -58,923,300 | -1,820,528 | -2,658,087 |
| Depreciation & Amortization | 4,641,417 | 21,656 | 5,671 |
| Stock Based Compensation | 0 | 0 | 0 |
| Change in Working Capital | 1,138,212 | 417,418 | 167,435 |
| Operating Cash Flow | -405,168 | -935,118 | -1,436,304 |
| Investing Activities | |||
| Capital Expenditure | 0 | -2 | 0 |
| Investments | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 |
| Financing Activities | |||
| Debt Repayment | 343,700 | 918,837 | 0 |
| Common Stock Issued/Repurchased | 51,348,000 | 23,057 | 99,285 |
| Dividends Paid | 0 | 0 | 0 |
| Financing Cash Flow | 490,756 | 941,894 | 1,490,786 |
| Summary | |||
| Free Cash Flow | -405,168 | -935,118 | -1,436,304 |
| Net Change in Cash | -8,997 | 11,038 | 1,812 |
| Cash Flow Statement (Annual) | 2025-06-30 | 2024-06-30 | 2022-06-30 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | -58,923,300 | -1,820,528 | -2,658,087 |
| Depreciation & Amortization | 4,641,417 | 21,656 | 5,671 |
| Stock Based Compensation | 0 | 0 | 0 |
| Change in Working Capital | 1,138,212 | 417,418 | 167,435 |
| Operating Cash Flow | -405,168 | -935,118 | -1,436,304 |
| Investing Activities | |||
| Capital Expenditure | 0 | -2 | 0 |
| Investments | 0 | 0 | 0 |
| Investing Cash Flow | 0 | 0 | 0 |
| Financing Activities | |||
| Debt Repayment | 343,700 | 918,837 | 0 |
| Common Stock Issued/Repurchased | 51,348,000 | 23,057 | 99,285 |
| Dividends Paid | 0 | 0 | 0 |
| Financing Cash Flow | 490,756 | 941,894 | 1,490,786 |
| Summary | |||
| Free Cash Flow | -405,168 | -935,118 | -1,436,304 |
| Net Change in Cash | -8,997 | 11,038 | 1,812 |